222 related articles for article (PubMed ID: 8639672)
1. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.
Cacia J; Keck R; Presta LG; Frenz J
Biochemistry; 1996 Feb; 35(6):1897-903. PubMed ID: 8639672
[TBL] [Abstract][Full Text] [Related]
2. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
[TBL] [Abstract][Full Text] [Related]
3. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
4. Humanization of an antibody directed against IgE.
Presta LG; Lahr SJ; Shields RL; Porter JP; Gorman CM; Fendly BM; Jardieu PM
J Immunol; 1993 Sep; 151(5):2623-32. PubMed ID: 8360482
[TBL] [Abstract][Full Text] [Related]
5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
6. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
7. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
9. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
10. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
Sompuram SR; Den W; Sharon J
J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
[TBL] [Abstract][Full Text] [Related]
12. N-terminal mutations in the anti-estradiol Fab 57-2 modify its hapten binding properties.
Saviranta PJauria P; Lamminmäki U; Hellman J; Eriksson S; Lövgren T
Protein Sci; 2000 Dec; 9(12):2547-56. PubMed ID: 11206076
[TBL] [Abstract][Full Text] [Related]
13. A highly conserved interspecies V(H) in the human genome.
Vogel M; Tschopp C; Bobrzynski T; Fux M; Stadler MB; Miescher SM; Stadler BM
J Mol Biol; 2004 Aug; 341(2):477-89. PubMed ID: 15276838
[TBL] [Abstract][Full Text] [Related]
14. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
15. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
[TBL] [Abstract][Full Text] [Related]
16. Replacing the complementarity-determining regions in a human antibody with those from a mouse.
Jones PT; Dear PH; Foote J; Neuberger MS; Winter G
Nature; 1986 May 29-Jun 4; 321(6069):522-5. PubMed ID: 3713831
[TBL] [Abstract][Full Text] [Related]
17. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody.
Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT
J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195
[TBL] [Abstract][Full Text] [Related]
18. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
20. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
